Amazon Taps $100B GLP-1 Market and Commits $25B to Anthropic
Amazon has rolled out GLP-1 weight loss treatments via One Medical, tapping a market projected to reach $100 billion by 2030 while integrating pharmacy and virtual consultations. The company also earmarked a $25 billion investment in AI developer Anthropic and saw its X-Energy IPO stake jump 25% in the first trading hour.
1. Healthcare Expansion with GLP-1 Treatments
Amazon has integrated GLP-1 weight loss treatments into its One Medical service, using virtual and pharmacy channels to offer hormone-based therapies. The initiative targets a global weight management market projected to reach $100 billion by 2030 and complements Amazon’s existing healthcare delivery infrastructure.
2. Major AI Investment in Anthropic
The company announced a $25 billion capital commitment to AI startup Anthropic, strengthening its position in generative AI and machine learning. This investment is part of Amazon’s broader strategy to expand AWS capabilities and compete more aggressively in high-performance AI services.
3. Climate Tech Stake Delivers IPO Gains
Earlier this month, Amazon monetized an investment in nuclear energy startup X-Energy after its IPO raised $1 billion and the shares surged 25% in the first hour. The stake sale underscores Amazon’s willingness to invest in climate technologies with upside potential and diversify its long-term capital allocations.